Business Development & Licensing:

WORKING TOGETHER BECAUSE
THE WORLD IS WAITING

INVENT WITH US

Bold, meaningful collaborations. It’s critically important that we get them right because our work has the potential to impact the lives of millions. With more than 100 business development transactions since 2015, our team has the experience of working with a broad range of partners through a wide spectrum of collaborations from early-stage science to clinical-stage programs. Whether your innovation is from academia or a biotechnology company, you will find our process to be rapid, clear and straightforward. We believe that by working together we can play a major role in transforming global health care. Together we can invent for life.


Ben Thorner, senior vice president and head, MRL Business Development & Licensing

“We understand how difficult the path from bench to bedside is, what may work and what may not. We strive to be an exemplary collaborator - working side-by-side, tackling the tough issues that arise towards a shared mission of bringing important new medicines to patients.”

Klaus Beck, head, Headquarters Search and Evaluation

“It is our job to not only know which companies and academic centers are making real advances, but also to track great science with the potential to address critical unmet needs. Merck is excited about collaborating with our current and future partners.”

OPEN TO INNOVATION

BD&L GLOBAL OFFICES

AREAS OF INTEREST

Our main focus is cutting-edge science regardless of therapeutic area or modality. We have high interest and internal expertise in:

Oncology and Immuno-Oncology

Neuroscience

Infectious Disease and Vaccines

Cardiometabolic Diseases

Immunology

OUR PARTNERS

PARTNERSHIP PROFILES

MODERNA: HARNESSING A BOLD, NEW MODALITY

Moderna is pioneering the development of novel drugs using messenger RNA (mRNA). Together, we are striving to advance transformative new vaccines and therapies for viral diseases and cancer

READ MORE

NGM BIO: TRANSFORMING THE FUTURE

Merck is supporting not just one, but multiple drug candidates from NGM’s innovative drug discovery engine. And to provide NGM with what they need to pursue their ambitious R&D goals and thrive, they have full research autonomy allowing them the freedom to follow their scientific instincts.

READ MORE

REACH OUT TO US

GREAT DRUGS BEGIN WITH A GREAT CONVERSATION.

We’re ready to have meaningful discussions about your work and your perspective. You’ll find us ready to listen because we believe that building strong external alliances is one of the most important jobs we have. Our Business Development & Licensing organization is comprised of experts in their fields who are ready to work with you — including teams based in key epicenters of biomedical innovation (Boston, West Coast, Europe, Asia Pacific and Japan).


NEWS AND EVENTS

Meet our BD&L team at an upcoming event

Life Sciences Future
Philadelphia, Pennsylvania
September 1, 2018

CNS Diseases Summit
Boston, Massachusetts
September 25-26, 2018

BioNetwork West
Laguna Nigel, California
October 10-12, 2018